Survival Benefit of Kidney Transplantation in HIV-infected Patients
Jayme E. Locke(New York University), Dorry L. Segev(New York University), Allan B. Massie(Johns Hopkins University), Jon J. Snyder(Hennepin Healthcare Research Institute), Deirdre Sawinski(University of Pennsylvania), Shikha Mehta(University of Alabama at Birmingham), Brittany A. Shelton(University of Alabama at Birmingham), Nicholas Salkowski(Pro Persona), Paul A. MacLennan(University of Alabama at Birmingham), S.K. Gustafson(HealthPartners), Rhiannon D. Reed(University of Alabama at Birmingham), Christine M. Durand(University of Maryland, Baltimore)
Cited by 97
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States
|American Journal of Kidney Diseases|2021|727